EHRCON25, openEHR's flagship global conference on electronic health record innovation, will gather health IT leaders from across South America, Africa,…
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that an analyst…
Advanced Lipedema Treatment (ALT) LOS ANGELES, CA / ACCESS Newswire / October 15, 2025 / Advanced Lipedema Treatment (ALT) is…
Pilot Study to Lay the Groundwork for Expansion Across JamaicaGoal of the Collaboration is to Demonstrate the Ability to Deliver…
New contribution will help expand access to care by strengthening the Patient Advocate Foundation's capacity to deliver essential services and…
Initial Conversion Price of $5.00 Per Share Representing a 280% Premium Over the Company’s Recent Closing Price of $1.78MELBOURNE, Australia,…
Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk’s Rare Disease portfolioOmeros is…
PRECISE study to generate pivotal clinical data for the Symani® Surgical System in free tissue transfer and lymphatic surgical repairJACKSONVILLE,…
SALT LAKE CITY, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its…
Initial target markets for commercialization include Germany, the Benelux countries, Austria, the United Kingdom, and Scandinavia Expands distributor channel coverage…